Mn Services Vermogensbeheer B.V. decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 4.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,048 shares of the medical instruments supplier's stock after selling 400 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Mettler-Toledo International were worth $9,504,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of the business. SBI Securities Co. Ltd. purchased a new position in Mettler-Toledo International in the 4th quarter valued at approximately $33,000. Edmond DE Rothschild Holding S.A. purchased a new position in Mettler-Toledo International during the fourth quarter worth $44,000. Whipplewood Advisors LLC purchased a new position in Mettler-Toledo International during the fourth quarter worth $54,000. Menard Financial Group LLC purchased a new position in Mettler-Toledo International during the fourth quarter worth $67,000. Finally, Farther Finance Advisors LLC increased its position in Mettler-Toledo International by 14.3% during the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock worth $78,000 after buying an additional 8 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.
Mettler-Toledo International Price Performance
MTD stock traded down $3.33 on Wednesday, hitting $1,147.24. 125,736 shares of the company were exchanged, compared to its average volume of 152,017. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The business's fifty day moving average is $1,111.61 and its two-hundred day moving average is $1,202.84. The stock has a market capitalization of $23.84 billion, a price-to-earnings ratio of 28.61, a price-to-earnings-growth ratio of 3.41 and a beta of 1.38.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. During the same period in the previous year, the company earned $8.89 EPS. The business's quarterly revenue was down 4.6% compared to the same quarter last year. Equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.
Insider Transactions at Mettler-Toledo International
In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director now directly owns 120 shares in the company, valued at $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.94% of the company's stock.
Wall Street Analysts Forecast Growth
MTD has been the subject of several analyst reports. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research note on Monday, April 7th. Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price target for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their target price for the stock from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Finally, Wells Fargo & Company lifted their target price on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $1,302.11.
Check Out Our Latest Report on Mettler-Toledo International
Mettler-Toledo International Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
